REPLIMUNE GROUP, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.43 USD | -5.58% |
|
-3.86% | -23.25% |
| 04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
| 03-26 | Replimune Group, Inc. Announces Management Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REPLIMUNE GROUP, INC. | Other Biotechnology & Medical Research | -4.92% | -3.86% | -23.25% | -65.01% | -57.27% | 418M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- REPL Stock
- Charts Replimune Group, Inc.
- Comparison Chart